Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalFRA:O66 -5.84%8 Net Current Asset Value is €0.07 as of Dec. 2025, which is 100% below its 10-year median of 82.54. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 77 Medical Distribution companies, 160 Health International ranks worse than 90.91% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
160 Health International's net current asset value per share for the quarter that ended in Dec. 2025 was €0.07.
The historical rank and industry rank for 160 Health International's Net Current Asset Value or its related term are showing as below:
FRA:O66'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 14.38 Med: 82.54 Max: 82.54
Current: 15.2
During the past 4 years, the highest Price-to-Net-Current-Asset-Value Ratio of 160 Health International was 82.54. The lowest was 14.38. And the median was 82.54.
FRA:O66's Price-to-Net-Current-Asset-Value is ranked worse than 90.91% of 77
companies
in the Medical Distribution industry
Industry Median: 3.41
vs FRA:O66: 15.20
160 Health International (FRA:O66) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
160 Health International Net Current Asset Value Related Terms
160 Health International Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for 160 Health International's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
160 Health International Net Current Asset Value Chart
FRA:O66 vs MCK, COR, CAH: Net Current Asset Value Comparison
For the Medical Distribution subindustry, 160 Health International's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where 160 Health International's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of €0.07 mean?
160 Health International (FRA:O66) has a Net Current Asset Value of €0.07 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on 160 Health International and its competitors. This is 100% below median its historical median of 82.54. Over the past decade, 160 Health International's Net Current Asset Value has ranged from 14.38 to 82.54. According to the industry distribution chart, 160 Health International ranks #70 out of 77 companies in the Medical Distribution industry, placing it in the top 90.9%.
Is 160 Health International's Net Current Asset Value too high?
160 Health International's current Net Current Asset Value of €0.07 is 100% below median its 10-year median of 82.54. Over the past 10 years, this metric has ranged from a low of 14.38 to a high of 82.54. Based on the distribution chart, 160 Health International ranks #70 out of 77 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Net Current Asset Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #70 out of 77 companies for Net Current Asset Value. This places 160 Health International in the lower half of its industry. The industry median Net Current Asset Value is 3.41. Historically, 160 Health International's own Net Current Asset Value has ranged from 14.38 to 82.54 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.41, based on 77 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current Net Current Asset Value is €0.07, which is 100% below median its own 10-year median of 82.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current Net Current Asset Value of €0.07. The current Net Current Asset Value is €0.07, which is 100% below median its 10-year median of 82.54. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current Net Current Asset Value is €0.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for FRA:O66
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:O66 has been successfully added to your 
